drugset / Trial / NCT00309530

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

NCT00309530

Phase 3 Completed 598 enrolled Austrian Breast & Colorectal Cancer Study Group
RandomizedFactorialOpen-labelTreatment

Summary

This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of recurrence-free and overall survival in curatively operable colon carcinoma Stage III.

Timeline

Start
1990-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Levamisole Small molecule
Subject fluorouracil Small molecule
Subject interferon alfa-2b Protein / enzyme biologic